Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872751 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 12 Pages |
Abstract
Prostate brachytherapy results in a high probability of 8-year biochemical progression-free survival for low-, intermediate-, and high-risk patients. Although the role of supplemental EBRT could not be adequately evaluated in high-risk patients, it did not improve biochemical outcome in low- and intermediate-risk patients. However, ADT resulted in a statistically significant improvement in progression-free survival for high-risk patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Gregory S. M.D., Wayne M. Ph.D., Kent E. M.D., Robert W. Ph.D., Jonathan H. Ph.D., Zachariah M.S., Edward M.D.,